These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


49 related items for PubMed ID: 9435376

  • 1. [Regulation of follicular luteinization by an agonist of gonadotropin-releasing hormone (GnRH)].
    Andreu C, Parborell F, Vanzulli S, Tesone M.
    Medicina (B Aires); 1997; 57(1):83-6. PubMed ID: 9435376
    [Abstract] [Full Text] [Related]

  • 2. Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: relationship between steroidogenesis and apoptosis.
    Andreu C, Parborell F, Vanzulli S, Chemes H, Tesone M.
    Mol Reprod Dev; 1998 Nov; 51(3):287-94. PubMed ID: 9771649
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone antagonist antide inhibits apoptosis of preovulatory follicle cells in rat ovary.
    Parborell F, Irusta G, Vitale A, Gonzalez O, Pecci A, Tesone M.
    Biol Reprod; 2005 Mar; 72(3):659-66. PubMed ID: 15564600
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin-releasing hormone agonist affects rat ovarian follicle development by interfering with FSH and growth factors on the prevention of apoptosis.
    Parborell F, Dain L, Tesone M.
    Mol Reprod Dev; 2001 Oct; 60(2):241-7. PubMed ID: 11553925
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA, Stirling D, Menzies GS, Baird DT.
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [Abstract] [Full Text] [Related]

  • 9. Incorporation of a GnRH agonist, leuprolide acetate, into regimens with exogenous gonadotropins to produce ovarian stimulation and ovulation in the nonpregnant squirrel monkey.
    Kuehl TJ, Davis TW, Young C, Nunez P, Robinson MR, Huddleston KP, Wincek TJ, Pliego JF, Dukelow WR.
    Am J Primatol; 1999 Oct; 49(2):153-64. PubMed ID: 10466574
    [Abstract] [Full Text] [Related]

  • 10. Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs.
    Parborell F, Irusta G, Rodríguez Celín A, Tesone M.
    Mol Reprod Dev; 2008 Apr; 75(4):623-31. PubMed ID: 17874466
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.
    Saatli B, Kizildag S, Posaci C, Dogan E, Koyuncuoglu M, Ulukus EC, Atabey N.
    Fertil Steril; 2009 May; 91(5 Suppl):2006-11. PubMed ID: 18829022
    [Abstract] [Full Text] [Related]

  • 12. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
    Peng P, Yang DZ, Zheng CY, Mo YQ, He YM, Zhang QX.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
    [Abstract] [Full Text] [Related]

  • 13. Reduced LH sensitivity in vivo and in vitro of corpora lutea induced during anoestrus by GnRH, and during the late breeding season, in Scottish Blackface ewes.
    Bramley TA, Stirling D, Menzies GS, Baird DT.
    J Endocrinol; 2004 Dec; 183(3):517-26. PubMed ID: 15590978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progesterone receptor activation mediates LH-induced type-I pituitary adenylate cyclase activating polypeptide receptor (PAC(1)) gene expression in rat granulosa cells.
    Ko C, Park-Sarge OK.
    Biochem Biophys Res Commun; 2000 Oct 14; 277(1):270-9. PubMed ID: 11027674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential gonadotropin releasing hormone (GnRH) expression, autoregulation and effects in two models of rat luteinized ovarian cells.
    Sorianello EM, Fernandez MO, Catalano PN, Mongiat LA, Somoza GM, Libertun C, Lux-Lantos VA.
    Life Sci; 2005 Sep 09; 77(17):2141-55. PubMed ID: 16005024
    [Abstract] [Full Text] [Related]

  • 18. Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women undergoing assisted reproduction.
    Silva AL, Abreu LG, Rosa-e-Silva AC, Ferriani RA, Silva-de-Sá MF.
    Steroids; 2008 Dec 22; 73(14):1475-84. PubMed ID: 18789958
    [Abstract] [Full Text] [Related]

  • 19. Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats.
    Goto T, Endo T, Henmi H, Kitajima Y, Kiya T, Nishikawa A, Manase K, Sato H, Kudo R.
    J Endocrinol; 1999 Jun 22; 161(3):393-402. PubMed ID: 10333542
    [Abstract] [Full Text] [Related]

  • 20. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone receptors and steroidogenesis in ovarian cells.
    Guerrero HE, Stein P, Asch RH, de Fried EP, Tesone M.
    Fertil Steril; 1993 Apr 22; 59(4):803-8. PubMed ID: 8458500
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.